Log in to save to my catalogue

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and mode...

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and mode...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2303106090

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

About this item

Full title

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2019-11, Vol.18 (11), p.1045-1057

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

The identification of anti-NMDA receptor (NMDAR) encephalitis about 12 years ago made it possible to recognise that some patients with rapidly progressive psychiatric symptoms or cognitive impairment, seizures, abnormal movements, or coma of unknown cause, had an autoimmune disease. In this disease, autoantibodies serve as a diagnostic marker and a...

Alternative Titles

Full title

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2303106090

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2303106090

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(19)30244-3

How to access this item